Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Wednesday 19 April, 2017

GlaxoSmithKline PLC

Director/PDMR Shareholding

RNS Number : 7740C
GlaxoSmithKline PLC
19 April 2017
 

GlaxoSmithKline plc (the 'Company')

 

Transaction notification

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mr D E Troy

b)

Position/status

SVP & General Counsel

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

American Depositary Shares ('ADSs')

 

ISIN: US37733W1053

b)

Nature of the transaction

Acquisition of ADSs following the re-investment of dividends paid to shareholders on 13 April 2017 on ADSs held in the Company's US Deferred Performance Share Plan.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

$41.81

6.362

$41.81

412.833

d)

Aggregated information

 

Aggregated volume Price

 

 

 

 

419.195

$41.81

e)

Date of the transaction

2017-04-18

f)

Place of the transaction

 

New York Stock Exchange (XNYS)

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHEKLFFDZFLBBX

a d v e r t i s e m e n t